---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-25-087080"
form_type: "8-K"
ticker: "COR"
cik: "0001140859"
company_name: "Cencora, Inc."
filed_at: "2025-09-03T23:59:59+00:00"
generated_at: "2026-05-17T08:26:45.535268+00:00"
event_type: "litigation"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Cencora reaches $111.3M settlement of derivative suit over opioid oversight

## Summary
- Insurance carriers to pay Cencora $111.3M (less attorney fees) to settle derivative claims over controlled substance diversion controls.
- Settlement subject to Delaware Chancery Court approval; defendants deny any wrongdoing or liability.
- Derivative complaint alleged breach of fiduciary duty by directors and officers for failing to monitor opioid compliance.
- Special Litigation Committee investigated and mediated the resolution; $111.25M mediator proposal accepted June 2025.
- Settlement separate from Cencora's prior $6.4B nationwide opioid distributor settlement.

## SEC filing metadata
- accession: 0001104659-25-087080
- form_type: 8-K
- ticker: COR
- cik: 0001140859
- company_name: Cencora, Inc.
- filed_at: 2025-09-03T23:59:59+00:00
- event_type: litigation
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1140859/000110465925087080/0001104659-25-087080-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1140859/000110465925087080/tm2524806d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-25-087080
- JSON: https://secwatch.observer/filing/0001104659-25-087080.json
- Plain text: https://secwatch.observer/filing/0001104659-25-087080.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.